【摘 要】
：
Atrial fibrillation (AF) is a supraventricular arrythmia characterized by uncoordinated atrial activation with consequent deterioration of mechanical function.AF is the most common rhythm disturbance,
【机 构】
：
Department of Cardiology St.Vincentius Hospital Academic Teaching Hospital of the University of Frei
【出 处】
：
BITs 2rd Annual World Cancer Congress of Cardiology-2010(201
论文部分内容阅读
Atrial fibrillation (AF) is a supraventricular arrythmia characterized by uncoordinated atrial activation with consequent deterioration of mechanical function.AF is the most common rhythm disturbance, increasing in prevalence with age.Stroke is a common complication of this arrythmia, which appears in about 6% of these patients.Maintenance of sinus rhythm is the goal of therapy.Drug therapy is disappointing-according to the last great study with antiarrhythmic drugs: the CTAF-study (2000).After 600 days of treatment only less than 40% of those treated with class IC drugs remained in sinus rhythm and 60% of those treated with amiodarone.
其他文献
A number of pathological eonditions, including chronic inflammation, generate conditions where low density lipoprotein (LDL) suffers oxidative, chemical and biological changes, thus producing modified
Lipoprotein-associated phospholipase A2 (Lp-PLA2) is today considered a novel specific vascular inflammatory biomarker.Specific aims for this study were to explore the association of Lp-PLA2 with trad
Cardiovascular disease remains the main cause of mortality and morbidity in subjects with diabetes.Moreover, the majority of individuals with cardiac ischemia display abnormalities in glucose metaboli
The purpose of this presentation is to review the beginnings of a new, non-invasive technology called Whole Body Periodic Acceleration (WBPA or pGz) that was discovered serendipitously as a result of
Periodic acceleration in the direction of the spinal axis through repetitive movements increases shear stress to the vascular endothelium.We assessed whether whole-body periodic acceleration with a ne
Whole-body periodic acceleration (WBPA) by using Acceleration Therapeutics (AT101, USA) is reported to up-regulate endothelial nitric oxide (NO) synthase (eNOS) in animal studies and to improve brachi
Background.Exercise training is beneficial in the primary and secondary prevention and treatment of coronary artery disease and a widening variety of other chronic diseases.However, moderate aerobic e
Purpose: We hypothesized that treatment with whole body periodic acceleration (WBPA) improves vascular endothelial function, and ameliorates exercise capacity as a result of increased peripheral vasod
Various tachyarrhythmias have become everyday challenge for clinicians caring for infants, children and adults with repaired or palliated congenital heart disease.The risk of atrial or ventricular tac
The purpose of this presentation is to review the investigations since 2001 carried out in my laboratory employing a new, non-invasive technology called Whole Body Periodic Acceleration (WBPA or pGz)